A61K 31/145
Having sulfur
Official title: having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2) (isothiourea A61K31/155)
A61K31/145 (Having sulfur) appears on 508 US grants and 989 published applications in this corpus.
Search patents in A61K- Granted patents
- 508
- Published applications
- 989
- Assignees
- 507
- Inventors
- 1,559
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 10 | 0 |
| 1999 | 13 | 0 |
| 2000 | 6 | 0 |
| 2001 | 7 | 3 |
| 2002 | 7 | 9 |
| 2003 | 6 | 11 |
| 2004 | 1 | 14 |
| 2005 | 2 | 10 |
| 2006 | 6 | 15 |
| 2007 | 2 | 9 |
| 2008 | 4 | 14 |
| 2009 | 2 | 19 |
| 2010 | 7 | 35 |
| 2011 | 5 | 30 |
| 2012 | 8 | 26 |
| 2013 | 13 | 35 |
| 2014 | 15 | 54 |
| 2015 | 23 | 53 |
| 2016 | 46 | 64 |
| 2017 | 29 | 74 |
| 2018 | 39 | 51 |
| 2019 | 44 | 63 |
| 2020 | 25 | 60 |
| 2021 | 35 | 72 |
| 2022 | 31 | 54 |
| 2023 | 37 | 61 |
| 2024 | 30 | 62 |
| 2025 | 18 | 53 |
| 2026 | 22 | 38 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of treating Prader Willi Syndrome and conditions associated with low basal metabolic rate or hyperphagia using a KATP channel opener29 Sep 2026US 12,746,244 B2Sedogen LLC
- Antiviral supplement formulations11 Aug 2026US 12,702,677 B2Vymedic, LLC
- Tetrahydrocurcumin compositions, methods of making, and methods of using the same4 Aug 2026US 12,697,311 B2Renibus Therapeutics, Inc.
- Compositions, methods of treatment, and containers including compositions21 Jul 2026US 12,685,715 B2University of Florida Research Foundation, Inc.
- Use of cysteamine and derivatives thereof to suppress tumor metastases30 Jun 2026US 12,667,547 B2Meshaberase, LLC
- Compositions, methods of treatment, and containers including compositions8 Oct 2026US 2026/0306427 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Use of CFTR Modulators For Treating Cerebrovascular Conditions24 Sep 2026US 2026/0284023 A1Qanatpharma AG
- Combinations including methocinnamox24 Sep 2026US 2026/0284035 A1Board of Regents, The University of Texas System
- Oral compositions containing methocinnamox24 Sep 2026US 2026/0284036 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Chemoprotective isothiocyanates86US 5,411,986 AThe Johns Hopkins University · 1995
- Asthma associated factors as targets for treating atopic allergies including asthma and related disorders84US 5,908,839 AMagainin Pharmaceuticals Inc. · 1999
- Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor80US 6,093,743 AMedinox, Inc. · 2000
- Regulation of wound healing by nitric oxide75US 6,190,704 B1New York Society for the Ruptured and Crippled Maintaining the Hospital for Special Surgery · 2001
- Treatment for atherosclerosis and other cardiovascular and inflammatory diseases63US 5,380,747 AEmory University · 1995